SFM
Sphera Funds Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.54M | Sell |
419,540
-88,289
| -17% | -$1.8M | 2% | 11 |
|
|
2025
Q1 | $9.22M | Buy |
507,829
+33,726
| +7% | +$612K | 2.12% | 10 |
|
|
2024
Q4 | $12M | Buy |
474,103
+55,000
| +13% | +$1.39M | 2.17% | 10 |
|
|
2024
Q3 | $14.2M | Buy |
419,103
+109,838
| +36% | +$3.73M | 2.27% | 10 |
|
|
2024
Q2 | $11.4M | Buy |
309,265
+32,269
| +12% | +$1.19M | 1.56% | 17 |
|
|
2024
Q1 | $11.6M | Sell |
276,996
-38,648
| -12% | -$1.62M | 1.63% | 16 |
|
|
2023
Q4 | $12.5M | Buy |
315,644
+135,644
| +75% | +$5.38M | 2.01% | 9 |
|
|
2023
Q3 | $4.95M | Buy |
180,000
+20,000
| +13% | +$550K | 0.9% | 35 |
|
|
2023
Q2 | $5.43M | Buy |
+160,000
| New | +$5.43M | 0.85% | 39 |
|
|
2022
Q1 | – | Sell |
-166,766
| Closed | -$6.44M | – | 70 |
|
|
2021
Q4 | $6.44M | Buy |
166,766
+36,436
| +28% | +$1.41M | 0.71% | 44 |
|
|
2021
Q3 | $7.04M | Buy |
+130,330
| New | +$7.04M | 0.59% | 45 |
|
|
2021
Q2 | – | Sell |
-220,320
| Closed | -$4.54M | – | 129 |
|
|
2021
Q1 | $4.54M | Sell |
220,320
-376,878
| -63% | -$7.76M | 0.35% | 65 |
|
|
2020
Q4 | $10.5M | Buy |
597,198
+227,198
| +61% | +$3.98M | 0.93% | 25 |
|
|
2020
Q3 | $5.49M | Buy |
+370,000
| New | +$5.49M | 0.54% | 48 |
|
|
2015
Q2 | – | Sell |
-105,000
| Closed | -$2.93M | – | 131 |
|
|
2015
Q1 | $2.93M | Buy |
+105,000
| New | +$2.93M | 0.3% | 76 |
|